Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 151 publications
Downstaging as a direct patient benefit in cancer screening.
Journal: Journal of medical screening
Published: July 31, 2026
The vanguard study: Assessing feasibility of conducting randomized trials of novel multi-cancer detection tests.
Journal: Contemporary clinical trials
Published: February 19, 2026
Performance of multiple multi-cancer detection tests using a large independent reference set (Alliance A212102).
Journal: Journal of the National Cancer Institute
Published: August 26, 2025
Performance of multiple multi-cancer detection tests using a large independent reference set (Alliance A212102).
Journal: Journal of the National Cancer Institute
Published: August 26, 2025
Impact of a Weight Loss Intervention on 1-Year Weight Change in Women With Stage II/III Breast Cancer: Secondary Analysis of the Breast Cancer Weight Loss (BWEL) Trial.
Journal: JAMA oncology
Published: August 21, 2025
Framework to Select Multi-Cancer Detection Assays in the National Cancer Institute's Vanguard Study.
Framework to Select Multi-Cancer Detection Assays in the National Cancer Institute's Vanguard Study.
Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: June 10, 2025
Cancer-related cognitive impairment: a review of National Institutes of Health‑Funded grants (2017-2024).
Journal: Journal of cancer survivorship : research and practice
Published: June 07, 2025
Chemotherapy-induced peripheral neuropathy research: a National Institutes of Health (NIH) grant portfolio analysis (2014-2023).
Journal: JNCI cancer spectrum
Published: January 28, 2025
Long-Term Adverse Effects and Complications After Prostate Cancer Treatment.
Journal: JAMA oncology
Published: November 07, 2024
Statistical properties of items and summary scores from the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE®) in a diverse cancer sample.
Journal: Clinical trials (London, England)
Published: October 23, 2024
Last Updated: 09/26/2026